Pharmaceutical Analytical Testing Outsourcing Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, South Korea, Mexico, Brazil, Argentina, Saudi Arabia, South Africa, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI4530
Pharmaceutical Analytical Testing Outsourcing Market size is expected to grow significantly from 2020 to 2026. Pharmaceutical analytical testing is majorly used in pharmaceutical and biopharmaceutical companies for series of clinical trials on new manufactured drugs to ensure safety. The drugs undergo bioanalytical testing, method development & validation and stability testing before the launch. Pharma companies are focusing on analytical testing outsourcing as it enhances drug safety and shortens drug development time.
Get more details on this report - Request Free Sample PDF
Pharmaceutical analytical testing outsourcing market is growing due to competition within pharmaceutical market for disease specific drugs. Pharmaceutical analytical testing involves identification and quantification of components in pharmaceutical solutions or drugs. Due to increasing demand for drugs, there is substantial growth in R&D investments. The lengthy drug approval procedures and financial issues leads to in reduced return on investments, thereby, increasing company’s preference towards outsourcing these services.
Furthermore, availability of advanced analytical testing techniques such as hyphenated technique, kinetic method of analysis, electrochemical techniques enables specific monitoring of components in drug development. However, high cost associated with pharmaceutical testing and varied outsourcing expenditures by companies may restrain pharmaceutical analytical testing outsourcing market growth over the forecast period.
Bioanalytical testing type segment is projected to witness profitable growth in forthcoming years. Technological advancement in the testing procedures have enabled rapid development of drugs. Bioanalytical testing is used for quantitative determination of xenobiotics i.e. drugs and its biological molecules or metabolites and biotics. These include biological systems such as DNA, blood, plasma, serum etc. For instance, bioanalytical testing involves liquid chromatography–mass spectrometry (LC-MS) for pharmaceutical and analytical compounds as well as metabolites in human and animals. Availability of such tests will spur segment size over the analysis period.
Active pharmaceutical ingredient segment will witness significant growth over the time period. Manufactures are focused on producing strong API drugs thus, increasing its therapeutic power and delivering demands of consumers and global competitors. The advantage of outsourcing API is reduction in investment for expensive containment infrastructure. There are certain CMOs and pharmaceutical companies that provide in-house toxicology and pharmacology expertise due to appropriate and safe infrastructure and stringent GMP obligations. The persistent growth of API manufacturers in rapidly changing pharmaceutical industry will prove beneficial for segment growth.
Biopharmaceuticals and pharmaceutical companies’ segment accounted for significant revenue share. The companies have adapted analytical testing outsourcing as it reduces cost and improves efficiency. The increasing demand of regulatory bodies for analytical details on drugs and competition among generic and biosimilars medications has been a driving factor of testing outsourcing market. Additionally, CROs are in favor of providing integrated services to CMOs and pharmaceutical companies to streamline the process and improve efficiency thereby, augmenting the segment growth in coming years.
Asia Pacific pharmaceutical analytical testing outsourcing market is estimated to show profitable growth in forecast period due to increasing development of pharmaceutical industries in India and China. Pharmaceutical key players are focusing towards Asia Pacific region due to low development cost, increased GMP compliances and capabilities to perform complex synthesis of drugs. The availability of bulk manufactures and low-cost drug delivery in India and China has augmented generic manufacture’s growth. The rapid investment by key players in Asia Pacific pharmaceutical market will foster the analytical testing outsourcing industry growth.
Some of the prominent players operating in pharmaceutical analytical testing outsourcing market share include West Pharmaceutical Services, Boston Analytical, Charles River Laboratories International, Bioreliance, WuXi AppTec. Industry players focus on inorganic strategic alliance such as acquisitions and mergers to increase their revenue and maintain market position.
Pharmaceutical Analytical Testing Outsourcing Market, By Services, 2015-2026 (USD Million)
- Bioanalytical Testing
- Method Development & Validation
- Extractable & Leachable
- Impurity Method
- Technical Consulting
- Stability Testing
- Drug Substance
- Stability Indicating Method Validation
- Accelerated Stability Testing
- Photostability Testing
By Product Type, 2015-2026 (USD Million)
- Active Pharmaceutical Ingredient (API)
- Finished Products
By End-use, 2015-2026 (USD Million)
- Biopharmaceuticals and Pharma Companies
- Contract Manufacturing organizations
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.